Breast (Edinburgh, Scotland)

Keyphrases

Publications

volume 78, 2024

Jannah Baker, Naomi Noguchi, M Luke Marinovich, Brian L Sprague, Elizabeth Salisbury, Nehmat Houssami
Atypical ductal or lobular hyperplasia, lobular carcinoma in-situ, flat epithelial atypia, and future risk of developing breast cancer: Systematic review and meta-analysis. Breast (Edinburgh, Scotland) 78 (2024)
Lei Ji, Xi Chen, Xiaoyan Qian, Min Xiao, Qing Li, Qiao Li, Jiayu Wang, Ying Fan, Yang Luo, Shanshan Chen, Fei Ma, Binghe Xu, Pin Zhang
Major pathologic response and long-term clinical benefit in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer after neoadjuvant chemotherapy. Breast (Edinburgh, Scotland) 78 (2024)
Rebecca Pedersini, Greta Schivardi, Marta Laganà, Lara Laini, Pierluigi di Mauro, Manuel Zamparini, Vito Amoroso, Alessia Bonalumi, Sara Bosio, Barbara Zanini, Chiara Buizza, Nicole Villa, Marco Ravanelli, Luca Rinaudo, Salvatore Grisanti, Davide Farina, Alfredo Berruti, Francesco Donato, Deborah Cosentini
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? Breast (Edinburgh, Scotland) 78 (2024)
Leonor Vasconcelos de Matos, Marcio Debiasi, Teresa Gantes Padrão, Berta Sousa, Fatima Cardoso
Can we counterbalance restricted access to innovation through specialized breast cancer care? The REAL-NOTE study. Breast (Edinburgh, Scotland) 78 (2024)
David Groheux, Sofia C Vaz, Philip Poortmans, Ritse M Mann, Gary A Ulaner, Gary J R Cook, Elif Hindié, John Patrick Pilkington Woll, Heather Jacene, Isabel T Rubio, Marie-Jeanne Vrancken Peeters, Elizabeth H Dibble, Lioe-Fee de Geus-Oei, Stephanie L Graff, Fatima Cardoso
Role of [ 18 F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines. Breast (Edinburgh, Scotland) 78 (2024)
Liang Li, Yutong Wang, Mingzhou Cai, Tonggang Fan
Effect of different exercise types on quality of life in patients with breast cancer: A network meta-analysis of randomized controlled trials. Breast (Edinburgh, Scotland) 78 (2024)
Ting-Na Wei, Jia-Fu Lin, Mei-Chun Cheng, Hui-Ling Yeh
Stereotactic body radiotherapy using CyberKnife versus interstitial brachytherapy in accelerated partial breast irradiation on left-sided breast: A comparison of dosimetric characteristics and preliminary clinical results. Breast (Edinburgh, Scotland) 78 (2024)
Karolina Larsson, Jamila Adra, Leif Klint, Barbro Linderholm
Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer - efficacy, tolerability and quality of life results from the phase II METRO trial. Breast (Edinburgh, Scotland) 78 (2024)
Sylvain Ladoire, Ariane Mamguem Kamga, Loick Galland, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai, Silvia Mihaelia Ilie, Audrey Hennequin, Clementine Jankowski, Juliette Albuisson, Sophie Nambot, Charles Coutant, Laurent Arnould, Manon Reda, Caroline Truntzer, Sandrine Dabakuyo
Real-world prevalence, treatment and survival of "high risk" early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry. Breast (Edinburgh, Scotland) 78 (2024)

volume 77, 2024

Smriti Raichand, Vendula Blaya-Novakova, Slavica Berber, Ann Livingstone, Naomi Noguchi, Nehmat Houssami
Digital breast tomosynthesis for breast cancer diagnosis in women with dense breasts and additional breast cancer risk factors: A systematic review. Breast (Edinburgh, Scotland) 77 (2024)
Yushuai Yu, Ruiliang Chen, Jialu Yi, Kaiyan Huang, Xin Yu, Jie Zhang, Chuangui Song
Non-invasive prediction of axillary lymph node dissection exemption in breast cancer patients post-neoadjuvant therapy: A radiomics and deep learning analysis on longitudinal DCE-MRI data. Breast (Edinburgh, Scotland) 77 (2024)
E G Engelhardt, R S J M Schmitz, M A Gerritsma, C M T Sondermeijer, E Verschuur, J H E Houtzager, R Griffioen, N Bijker, R M Mann, V Retèl, F H van Duijnhoven, J Wesseling, E M A Bleiker, null null
DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCIS. Breast (Edinburgh, Scotland) 77 (2024)
Eleonora Pagan, Monica Ruggeri, Nadia Bianco, Eraldo Oreste Bucci, Rossella Graffeo, Markus Borner, Monica Giordano, Lorenzo Gianni, Manuela Rabaglio, Andrea Freschi, Elisabetta Cretella, Elena Seles, Alberto Farolfi, Edda Simoncini, Mariangela Ciccarese, Daniel Rauch, Adolfo Favaretto, Friedemann Honecker, Rossana Berardi, Alessandra Franzetti-Pellanda, Shari Gelber, Ann H Partridge, Aron Goldhirsch, Vincenzo Bagnardi, Olivia Pagani, Karin Ribi
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer. Breast (Edinburgh, Scotland) 77 (2024)
Thomas Hubbard, Georgia Wright, Jenna Morgan, Charlene Martin, Stephen Walters, Kwok-Leung Cheung, Riccardo Audisio, Malcolm Reed, Lynda Wyld, null null
Management and outcomes for older women with early breast cancer treated with primary endocrine therapy (PET). Breast (Edinburgh, Scotland) 77 (2024)
Rui Tian, Yu Zheng, Ruikang Liu, Chen Jiang, Hongmei Zheng
Efficacy and safety of oncoplastic breast-conserving surgery versus conventional breast-conserving surgery: An updated meta-analysis. Breast (Edinburgh, Scotland) 77 (2024)
Chiara Marzorati, Marianna Masiero, Gabriella Pravettoni
"Perspective: An integrated vision of the quality of life in breast cancer survivorship trajectory". Breast (Edinburgh, Scotland) 77 (2024)
Luqi Chen, Stuart A McIntosh, Siddharth Tyagi, David Dodwell
Locoregional recurrence in studies of primary systemic therapy in early invasive breast cancer. Breast (Edinburgh, Scotland) 77 (2024)
Seong-Hyuk Park, Yun-Jung Yang, Sihyun Sung, Yelim Choi, Eun-Jung Yang
Postoperative complications of hypofractionated and conventional fractionated radiation therapy in patients with implant-based breast reconstruction: A systematic review and meta-analysis. Breast (Edinburgh, Scotland) 77 (2024)
Rui Tian, Yu Zheng, Ruikang Liu, Chen Jiang, Hongmei Zheng
Efficacy and safety of oncoplastic breast-conserving surgery versus conventional breast-conserving surgery: An updated meta-analysis. Breast (Edinburgh, Scotland) 77 (2024)
Tzu-Yu Lai, Yu-Wen Hu, Ti-Hao Wang, Jui-Pin Chen, Cheng-Ying Shiau, Pin-I Huang, I-Chun Lai, Yu-Ming Liu, Chi-Cheng Huang, Ling-Ming Tseng, Nicole Huang, Chia-Jen Liu
Estimating the risk of major adverse cardiac events following radiotherapy for left breast cancer using a modified generalized Lyman normal-tissue complication probability model. Breast (Edinburgh, Scotland) 77 (2024)
Caterina Caminiti, Giuseppe Maglietta, Laura Arenare, Raimondo Di Liello, Gessica Migliaccio, Daniela Barberio, Michelino De Laurentiis, Francesca Di Rella, Francesco Nuzzo, Carmen Pacilio, Giovanni Iodice, Michele Orditura, Fortunato Ciardiello, Sara Di Bella, Luigi Cavanna, Camillo Porta, Filippo Giovanardi, Carla Ida Ripamonti, Domenico Bilancia, Giuseppe Aprile, Tommaso Ruelle, Francesca Diodati, Maria Carmela Piccirillo, Elisabetta Iannelli, Carmine Pinto, Francesco Perrone
Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study. Breast (Edinburgh, Scotland) 77 (2024)
José Enrique Alés-Martínez, Judith Balmaña, Pedro Sánchez-Rovira, Francisco Javier Salvador Bofill, Jose Ángel García Sáenz, Isabel Pimentel, Serafín Morales, María Fernández-Abad, Ainhara Lahuerta Martínez, Neus Ferrer, Pilar Zamora, Begoña Bermejo, Tamara Díaz-Redondo, María Helena López-Ceballos, María Galán, Jhudit Pérez-Escuredo, Laura Calabuig, Miguel Sampayo, José Manuel Pérez-Garcia, Javier Cortés, Antonio Llombart-Cussac
Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study. Breast (Edinburgh, Scotland) 77 (2024)
Yael Bar, Kfir Bar, Didi Feldman, Judith Ben- Dror, Meishar Shahoha, Shir Lerner, Shlomit Strulov Shachar, Ahuva Weiss-Meilik, Nachum Dershowitz, Ido Wolf, Amir Sonnenblick
The impact of extensive intraductal component (EIC) on the genomic risk of recurrence in early hormone receptor positive breast cancer. Breast (Edinburgh, Scotland) 77 (2024)
Stacy M Carter, Diana Popic, M Luke Marinovich, Lucy Carolan, Nehmat Houssami
Women's views on using artificial intelligence in breast cancer screening: A review and qualitative study to guide breast screening services. Breast (Edinburgh, Scotland) 77 (2024)
Eleonora Pagan, Monica Ruggeri, Nadia Bianco, Eraldo Oreste Bucci, Rossella Graffeo, Markus Borner, Monica Giordano, Lorenzo Gianni, Manuela Rabaglio, Andrea Freschi, Elisabetta Cretella, Elena Seles, Alberto Farolfi, Edda Simoncini, Mariangela Ciccarese, Daniel Rauch, Adolfo Favaretto, Friedemann Honecker, Rossana Berardi, Alessandra Franzetti-Pellanda, Shari Gelber, Ann H Partridge, Aron Goldhirsch, Vincenzo Bagnardi, Olivia Pagani, Karin Ribi
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer. Breast (Edinburgh, Scotland) 77 (2024)
Luca Arecco, Maria Maddalena Latocca, Eva Blondeaux, Ferdinando Riccardi, Carmela Mocerino, Valentina Guarneri, Eleonora Mioranza, Giancarlo Bisagni, Elisa Gasparini, Fabio Puglisi, Alexandro Membrino, Antonella Ferro, Vincenzo Adamo, Filippo Giovanardi, Stefano Tamberi, Sara Donati, Elisabetta Landucci, Laura Biganzoli, Sara Piccinini, Simona Pastorino, Evandro de Azambuja, Francesca Poggio, Matteo Lambertini, Lucia Del Mastro
Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study. Breast (Edinburgh, Scotland) 77 (2024)
Seong-Hyuk Park, Yun-Jung Yang, Sihyun Sung, Yelim Choi, Eun-Jung Yang
Postoperative complications of hypofractionated and conventional fractionated radiation therapy in patients with implant-based breast reconstruction: A systematic review and meta-analysis. Breast (Edinburgh, Scotland) 77 (2024)
Thomas Hubbard, Georgia Wright, Jenna Morgan, Charlene Martin, Stephen Walters, Kwok-Leung Cheung, Riccardo Audisio, Malcolm Reed, Lynda Wyld, null null
Management and outcomes for older women with early breast cancer treated with primary endocrine therapy (PET). Breast (Edinburgh, Scotland) 77 (2024)
A Dezellus, S Mirallie, F Leperlier, B Sauterey, P-E Bouet, A Dessaint, S Duros, A S Gremeau, M-A Mouret-Reynier, L M Durand, L Venat, P De Blay, M Robert, T Freour, M Campone, A Blanc-Lapierre, V Bordes
Use of tamoxifene-controlled ovarian hyperstimulation for fertility preservation before breast cancer treatment: A prospective cohort study with a 5-year follow-up. Breast (Edinburgh, Scotland) 77 (2024)
José Enrique Alés-Martínez, Judith Balmaña, Pedro Sánchez-Rovira, Francisco Javier Salvador Bofill, Jose Ángel García Sáenz, Isabel Pimentel, Serafín Morales, María Fernández-Abad, Ainhara Lahuerta Martínez, Neus Ferrer, Pilar Zamora, Begoña Bermejo, Tamara Díaz-Redondo, María Helena López-Ceballos, María Galán, Jhudit Pérez-Escuredo, Laura Calabuig, Miguel Sampayo, José Manuel Pérez-Garcia, Javier Cortés, Antonio Llombart-Cussac
Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study. Breast (Edinburgh, Scotland) 77 (2024)
Stacy M Carter, Diana Popic, M Luke Marinovich, Lucy Carolan, Nehmat Houssami
Women's views on using artificial intelligence in breast cancer screening: A review and qualitative study to guide breast screening services. Breast (Edinburgh, Scotland) 77 (2024)
Bo Lan, Xuenan Peng, Fei Ma
Questionnaire survey and analysis of drug clinical research implementation capabilities of breast cancer treatment departments in Chinese hospitals. Breast (Edinburgh, Scotland) 77 (2024)
E G Engelhardt, R S J M Schmitz, M A Gerritsma, C M T Sondermeijer, E Verschuur, J H E Houtzager, R Griffioen, N Bijker, R M Mann, V Retèl, F H van Duijnhoven, J Wesseling, E M A Bleiker, null null
DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCIS. Breast (Edinburgh, Scotland) 77 (2024)
Bo Lan, Xuenan Peng, Fei Ma
Questionnaire survey and analysis of drug clinical research implementation capabilities of breast cancer treatment departments in Chinese hospitals. Breast (Edinburgh, Scotland) 77 (2024)
Caterina Caminiti, Giuseppe Maglietta, Laura Arenare, Raimondo Di Liello, Gessica Migliaccio, Daniela Barberio, Michelino De Laurentiis, Francesca Di Rella, Francesco Nuzzo, Carmen Pacilio, Giovanni Iodice, Michele Orditura, Fortunato Ciardiello, Sara Di Bella, Luigi Cavanna, Camillo Porta, Filippo Giovanardi, Carla Ida Ripamonti, Domenico Bilancia, Giuseppe Aprile, Tommaso Ruelle, Francesca Diodati, Maria Carmela Piccirillo, Elisabetta Iannelli, Carmine Pinto, Francesco Perrone
Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study. Breast (Edinburgh, Scotland) 77 (2024)
Luca Arecco, Maria Maddalena Latocca, Eva Blondeaux, Ferdinando Riccardi, Carmela Mocerino, Valentina Guarneri, Eleonora Mioranza, Giancarlo Bisagni, Elisa Gasparini, Fabio Puglisi, Alexandro Membrino, Antonella Ferro, Vincenzo Adamo, Filippo Giovanardi, Stefano Tamberi, Sara Donati, Elisabetta Landucci, Laura Biganzoli, Sara Piccinini, Simona Pastorino, Evandro de Azambuja, Francesca Poggio, Matteo Lambertini, Lucia Del Mastro
Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study. Breast (Edinburgh, Scotland) 77 (2024)
Patrick Maisonneuve, Roberto Orecchia
Meta-analysis of intraoperative electron radiation therapy for partial breast irradiation in early breast cancer. Breast (Edinburgh, Scotland) 77 (2024)
Smriti Raichand, Vendula Blaya-Novakova, Slavica Berber, Ann Livingstone, Naomi Noguchi, Nehmat Houssami
Digital breast tomosynthesis for breast cancer diagnosis in women with dense breasts and additional breast cancer risk factors: A systematic review. Breast (Edinburgh, Scotland) 77 (2024)
Caterina Caminiti, Giuseppe Maglietta, Laura Arenare, Raimondo Di Liello, Gessica Migliaccio, Daniela Barberio, Michelino De Laurentiis, Francesca Di Rella, Francesco Nuzzo, Carmen Pacilio, Giovanni Iodice, Michele Orditura, Fortunato Ciardiello, Sara Di Bella, Luigi Cavanna, Camillo Porta, Filippo Giovanardi, Carla Ida Ripamonti, Domenico Bilancia, Giuseppe Aprile, Tommaso Ruelle, Francesca Diodati, Maria Carmela Piccirillo, Elisabetta Iannelli, Carmine Pinto, Francesco Perrone
Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study. Breast (Edinburgh, Scotland) 77 (2024)
Yael Bar, Kfir Bar, Didi Feldman, Judith Ben- Dror, Meishar Shahoha, Shir Lerner, Shlomit Strulov Shachar, Ahuva Weiss-Meilik, Nachum Dershowitz, Ido Wolf, Amir Sonnenblick
The impact of extensive intraductal component (EIC) on the genomic risk of recurrence in early hormone receptor positive breast cancer. Breast (Edinburgh, Scotland) 77 (2024)

volume 76, 2024

Ru Wang, Bin Wang, Huimin Zhang, Xiaoqin Liao, Bohui Shi, Yuhui Zhou, Can Zhou, Yu Yan, Wei Zhang, Ke Wang, Guanqun Ge, Yu Ren, Xiaojiang Tang, Baoyu Gan, Jianjun He, Ligang Niu
Early evaluation of circulating tumor DNA as marker of therapeutic efficacy and prognosis in breast cancer patients during primary systemic therapy. Breast (Edinburgh, Scotland) 76 (2024)
Fatima Cardoso, Shani Paluch-Shimon, Eva Schumacher-Wulf, Leonor Matos, Karen Gelmon, Matti S Aapro, Jyoti Bajpai, Carlos H Barrios, Jonas Bergh, Elizabeth Bergsten-Nordström, Laura Biganzoli, Maria João Cardoso, Lisa A Carey, Chavez-MacGregor Mariana, Runcie Chidebe, Javier Cortés, Giuseppe Curigliano, Rebecca A Dent, Nagi S El Saghir, Alexandru Eniu, Lesley Fallowfield, Prudence A Francis, Sandra X Franco Millan, Jenny Gilchrist, Joseph Gligorov, William J Gradishar, Renate Haidinger, Nadia Harbeck, Xichun Hu, Ranjit Kaur, Belinda Kiely, Sung-Bae Kim, Smruti Koppikar, Marion J J Kuper-Hommel, Frédéric E Lecouvet, Ginny Mason, Shirley A Mertz, Volkmar Mueller, Claire Myerson, Silvia Neciosup, Birgitte V Offersen, Shinji Ohno, Olivia Pagani, Ann H Partridge, Frédérique Penault-Llorca, Aleix Prat, Hope S Rugo, Elzbieta Senkus, George W Sledge, Sandra M Swain, Christoph Thomssen, Daniel A Vorobiof, Peter Vuylsteke, Theresa Wiseman, Binghe Xu, Alberto Costa, Larry Norton, Eric P Winer
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7). Breast (Edinburgh, Scotland) 76 (2024)
V R Robins, S Gelcich, K Absolom, G Velikova
The impact of age on physical functioning after treatment for breast cancer, as measured by patient-reported outcome measures: A systematic review. Breast (Edinburgh, Scotland) 76 (2024)
Fatima Cardoso, Shani Paluch-Shimon, Eva Schumacher-Wulf, Leonor Matos, Karen Gelmon, Matti S Aapro, Jyoti Bajpai, Carlos H Barrios, Jonas Bergh, Elizabeth Bergsten-Nordström, Laura Biganzoli, Maria João Cardoso, Lisa A Carey, Mariana Chavez Mac Gregor, Runcie Chidebe, Javier Cortés, Giuseppe Curigliano, Rebecca A Dent, Nagi S El Saghir, Alexandru Eniu, Lesley Fallowfield, Prudence A Francis, Sandra X Franco Millan, Jenny Gilchrist, Joseph Gligorov, William J Gradishar, Renate Haidinger, Nadia Harbeck, Xichun Hu, Ranjit Kaur, Belinda Kiely, Sung-Bae Kim, Smruti Koppikar, Marion J J Kuper-Hommel, Frédéric E Lecouvet, Ginny Mason, Shirley A Mertz, Volkmar Mueller, Claire Myerson, Silvia Neciosup, Birgitte V Offersen, Shinji Ohno, Olivia Pagani, Ann H Partridge, Frédérique Penault-Llorca, Aleix Prat, Hope S Rugo, Elzbieta Senkus, George W Sledge, Sandra M Swain, Christoph Thomssen, Daniel A Vorobiof, Peter Vuylsteke, Theresa Wiseman, Binghe Xu, Alberto Costa, Larry Norton, Eric P Winer
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7). Breast (Edinburgh, Scotland) 76 (2024)
Serena Di Cosimo, José Manuel Pérez-García, Meritxell Bellet, Florence Dalenc, Miguel J Gil Gil, Manuel Ruiz-Borrego, Joaquín Gavilá, Elena Aguirre, Peter Schmid, Frederik Marmé, Joseph Gligorov, Andreas Schneeweiss, Joan Albanell, Pilar Zamora, Duncan Wheatley, Eduardo Martínez de Dueñas, Kepa Amillano, Eileen Shimizu, Miguel Sampayo-Cordero, Javier Cortés, Antonio Llombart-Cussac
Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer. Breast (Edinburgh, Scotland) 76 (2024)
Cynthia Aristei, Federico Camilli, Valeria Epifani, Simona Borghesi, Isabella Palumbo, Vittorio Bini, Philip Poortmans
A systematic review and meta-analysis of intraoperative electron radiation therapy delivered with a dedicated mobile linac for partial breast irradiation in early breast cancer. Breast (Edinburgh, Scotland) 76 (2024)
Yingyu Lin, Jifei Wang, Meizhi Li, Chunxiang Zhou, Yangling Hu, Mengyi Wang, Xiaoling Zhang
Prediction of breast cancer and axillary positive-node response to neoadjuvant chemotherapy based on multi-parametric magnetic resonance imaging radiomics models. Breast (Edinburgh, Scotland) 76 (2024)
Qianyi Lu, Hanxing Zhou, Jianwei Zhang, Kaping Lee, Limin Chen, Ruoxi Hong, Kuikui Jiang, Fei Xu, Wen Xia, Boyang Cao, Jingmin Zhang, Kang Shao, Peng Sun, Shusen Wang
Clinicopathological characteristics and genomic profiling of pure mucinous breast cancer. Breast (Edinburgh, Scotland) 76 (2024)
R Rosenfeld, S Riondino, M Cerocchi, A Luciano, G Idone, D Lecis, F Illuminato, A Tolomei, F Torino, M Chiocchi, M Roselli
Extracellular volume measured by whole body CT scans predicts chronic cardiotoxicity in breast cancer patients treated with neoadjuvant therapies based on anthracyclines: A retrospective study. Breast (Edinburgh, Scotland) 76 (2024)
Menekse Turna, Berna Akkus Yıldırım, Çakır Numanoglu, Mustafa Halil Akboru, Rashad Rzazade, Hale Başak Çağlar
Comprehensive analysis of stereotactic Radiosurgery outcomes in triple-negative breast cancer patients with brain metastases: The influence of immunotherapy and prognostic factors. Breast (Edinburgh, Scotland) 76 (2024)